Product Information

DIFLUNISAL 500 MG TABLET is a generic product labeled by Heritage Pharmaceuticals Inc., priced at $1.0427 per EA under NDC 14539067301. Its NADAC has been published 347 times since Nov 13, 2019.

FDA first approved this application on Mar 8, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DIFLUNISAL 500 MG TABLET

diflunisal
$1.0427per EA

Strength

500 mg/1

NDC

14539067301

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

DIFLUNISAL

Approval Type

Generic (ANDA)

FDA Application

ANDA202845

FDA Approved

3/8/2012

TE Code

AB

On Market Since

3/8/2012

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for DIFLUNISAL 500 MG TABLET has been published 347 times since Nov 13, 2019, and over the history we have for it it has declined 16.6%. The table below summarizes its recorded NADAC range and movement.

Current price$1.0427 per EA
All-time high$1.4281 (Jun 10, 2020)
All-time low$0.8327 (Dec 21, 2022)
52-week high$1.1995
52-week low$1.0380
Median price$1.0820
Average price$1.0961
Largest weekly change-29.8% (Dec 21, 2022)
Weeks tracked347
Tracking sinceNov 13, 2019

Price History

1W

+0.4%

1M

+0.4%

3M

-6.3%

6M

-13.1%

1Y

-1.6%

3Y

+8.0%

5Y

-25.3%

All

-16.6%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of DIFLUNISAL 500 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for DIFLUNISAL 500 MG TABLET, manufactured by Heritage Pharmaceuticals Inc., is $1.0427 per EA (NDC 14539067301), effective Aug 19, 2026.

How has the price of DIFLUNISAL 500 MG TABLET changed over time?

Over the history we have for it, the NADAC for DIFLUNISAL 500 MG TABLET has declined 16.6%. It has been tracked across 347 weekly CMS publications since Nov 13, 2019.

What are the highest and lowest recorded NADAC prices for DIFLUNISAL 500 MG TABLET?

Since Nov 13, 2019, the NADAC for DIFLUNISAL 500 MG TABLET has ranged from a low of $0.8327 (Dec 21, 2022) to a high of $1.4281 (Jun 10, 2020), with a median of $1.0820 per EA.

Are there cheaper alternatives to DIFLUNISAL 500 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DIFLUNISAL 500 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures DIFLUNISAL 500 MG TABLET?

DIFLUNISAL 500 MG TABLET (NDC 14539067301) is labeled by Heritage Pharmaceuticals Inc., and CMS classifies it as a generic product.